SILVERBACK THERAPEUTICS INC (SBTX)
US82835W1080 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 203.22M | 254.04M | 386.60M | 10.00M | 20.20M | |||
| Marketable Securities | 63.40M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 4.17M | 7.45M | 4.10M | 600.00K | 600.00K | |||
| Total Current Assets | 270.80M | 261.49M | 390.70M | 10.50M | 20.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.00K | 6.95M | 3.80M | 4.60M | 6.00M | |||
| Investments And Advances | 0.00 | 64.78M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 250.00K | 250.00K | 400.00K | 600.00K | 800.00K | |||
| Total Non-Current Assets | 265.00K | 71.97M | 4.10M | 5.10M | 6.70M | |||
| TOTAL ASSETS | 271.06M | 333.47M | 394.80M | 15.60M | 27.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 800.00K | 11.50M | 2.80M | |||
| Accrued Expenses | 3.86M | 12.81M | 6.20M | 2.90M | 1.50M | |||
| Accounts Payable | 126.00K | 2.08M | 2.60M | 3.50M | 800.00K | |||
| Total Current Liabilities | 3.99M | 14.89M | 9.60M | 17.90M | 5.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 4.76M | 2.30M | 3.30M | 4.20M | |||
| Total Non-Current Liabilities | 0.00 | 4.76M | 2.30M | 3.40M | 4.30M | |||
| TOTAL LIABILITIES | 3.99M | 19.65M | 11.90M | 21.30M | 9.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -248.14M | -186.21M | -96.70M | -63.80M | -39.80M | |||
| Additional Paid In Capital | 516.83M | 500.35M | 479.60M | 5.00M | 4.80M | |||
| Common Shares | 4.00K | 4.00K | 0.00 | 53.20M | 53.20M | |||
| Other Shareholders' Equity | -1.62M | -326.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 35.88M | 35.11M | 33.10M | 33.10M | 33.10M | |||
| Tangible Book Value per Share | 7.44 | 8.94 | 11.57 | -1.78 | -1.06 | |||
| Total Shareholders' Equity | 267.07M | 313.81M | 382.90M | -5.60M | 18.20M | |||
| TOTAL LIABILITIES AND EQUITY | 271.06M | 333.47M | 394.80M | 15.60M | 27.50M | |||
| Statistics | ||||||||
| Current Ratio | 67.87 | 17.56 | 40.70 | 0.59 | 4.08 | |||
| Return On Assets (ROA) | -31.50% | -26.83% | -8.35% | -153.65% | -63.93% | |||
| Return On Equity (ROE) | -31.97% | -28.51% | -8.61% | N/A | -96.59% | |||
All data in USD